Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of Sodium Valproate and Valproic Acid Extended Release Tablets in Healthy Human Volunteers

NCT05641649 is registered in ClinicalTrials.gov with Kathmandu University as lead sponsor.

NCT NCT05641649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05641649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of Sodium Valproate and Valproic Acid Extended Release Tablets in Healthy Human Volunteers
Lead sponsor
Kathmandu University
Phase
Phase 4
Overall status
Unknown status
Start date
August 6, 2023
Completion date
November 30, 2023
Enrollment
16 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy